StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

CASI Pharmaceuticals's total assets was $25.65M at Dec 31, 2025. For fiscal 2025 it was $25.65M, down 52.2% from the year before. The highest annual figure on record is $138.30M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$25.65M-52.2%
FY2024Dec 31, 2024$53.67M-28.7%
FY2023Dec 31, 2023$75.27M-21.8%
FY2022Dec 31, 2022$96.23M-30.4%
FY2021Dec 31, 2021$138.30M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$25.65M-81.5%
Q4 FY2024Dec 31, 2024$53.67M–
Q4 FY2023Dec 31, 2023$75.27M–
Q4 FY2022Dec 31, 2022$96.23M–
Q4 FY2021Dec 31, 2021$138.30M–

More CASI Pharmaceuticals figures

See a number that looks wrong?